At Sanger Health, we are a drug development regulatory consulting firm passionate about helping innovators cut through the regulatory landscape.
Founded by Matthew Lundberg, a lawyer with a scientific background and a deep empathy for both small and large biotech and pharmaceutical companies, Sanger Health is grounded in the belief that efficient and strategic drug development saves lives.
We specialize in pre-IND strategy, regulatory planning, IND submission support, and FDA communications. From early-stage development to IND preparation, we ensure your product has a clear and efficient path from discovery to first-in-human trials. Whether you're designing your initial clinical study or mapping out a long-term regulatory roadmap, we provide expert guidance tailored to your technology, team, and goals.
With deep expertise in early-stage drug development and a science-driven approach, we partner with emerging biotech teams to craft regulatory strategies that accelerate progress while reducing risk. We believe regulatory strategy should be a catalyst, not a barrier, to scientific innovation. That’s why our support is deeply personalized and fully aligned with your development vision.
What sets us apart is our efficiency, outcome-driven mindset, and genuine empathy for the challenges drug developers face. We work with biotechnology and pharmaceutical companies of all sizes to help them advance life-saving therapies with confidence.
Our mission is simple: make the regulatory process not just navigable, but strategic, so transformative treatments can reach the patients who need them.